Published in Clin Infect Dis on October 01, 1996
Vancomycin-resistant enterococci. Clin Microbiol Rev (2000) 5.61
Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev (2000) 2.27
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol (1997) 2.02
Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis (2012) 1.96
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother (2002) 1.71
Emergence of new pathogens as a function of changes in host susceptibility. Emerg Infect Dis (1997) 1.21
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect (2010) 1.16
Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother (2013) 1.02
Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes. Antimicrob Agents Chemother (2003) 0.89
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis (2006) 0.83
Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience. Clin Infect Dis (2015) 0.81
Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia. BMC Infect Dis (2014) 0.81
Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. World J Gastroenterol (2014) 0.78
First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia. Emerg Infect Dis (2002) 0.77
Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome. Biomed Res Int (2014) 0.75
Iron-Related Markers are Associated with Infection after Liver Transplantation. Liver Transpl (2017) 0.75
Consequences of reducing nonresponse in a national telephone survey. Public Opin Q (2000) 7.67
Conduction and selectivity in potassium channels. J Membr Biol (1983) 6.41
Open-state substructure of single chloride channels from Torpedo electroplax. Philos Trans R Soc Lond B Biol Sci (1982) 5.26
Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature (1985) 4.95
An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73
Human p53 gene localized to short arm of chromosome 17. Nature (1986) 4.67
Nonequilibrium gating and voltage dependence of the ClC-0 Cl- channel. J Gen Physiol (1996) 4.24
Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A (1987) 4.21
Discrete Ba2+ block as a probe of ion occupancy and pore structure in the high-conductance Ca2+ -activated K+ channel. J Gen Physiol (1988) 4.05
Fertilization-independent seed development in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1997) 3.87
Potassium blocks barium permeation through a calcium-activated potassium channel. J Gen Physiol (1988) 3.82
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res (1998) 3.77
Single chloride channels from Torpedo electroplax. Activation by protons. J Gen Physiol (1983) 3.76
Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA (2000) 3.64
Prevalence of vitamin B12 deficiency among geriatric outpatients. J Fam Pract (1992) 3.52
Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J Gen Physiol (1988) 3.48
Homodimeric architecture of a ClC-type chloride ion channel. Nature (1996) 3.47
Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol (1991) 3.45
Single streptomyces lividans K(+) channels: functional asymmetries and sidedness of proton activation. J Gen Physiol (1999) 3.42
Consensus statement on the live organ donor. JAMA (2000) 3.29
Multi-ion conduction and selectivity in the high-conductance Ca++-activated K+ channel from skeletal muscle. Biophys J (1986) 3.24
KcsA: it's a potassium channel. J Gen Physiol (2001) 3.23
Dimeric structure of single chloride channels from Torpedo electroplax. Proc Natl Acad Sci U S A (1984) 3.22
Ionic selectivity, saturation, and block in a K+-selective channel from sarcoplasmic reticulum. J Gen Physiol (1980) 3.16
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med (1993) 3.13
Percutaneous injuries during surgical procedures. JAMA (1992) 3.01
A DNA-activated protein kinase from HeLa cell nuclei. Mol Cell Biol (1990) 2.95
Language discrimination by human newborns and by cotton-top tamarin monkeys. Science (2000) 2.89
Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength. J Gen Physiol (1988) 2.87
Bis-quaternary ammonium blockers as structural probes of the sarcoplasmic reticulum K+ channel. J Gen Physiol (1982) 2.87
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1997) 2.84
Problems associated with early discharge of newborn infants. Early discharge of newborns and mothers: a critical review of the literature. Pediatrics (1995) 2.82
Steady-state coupling of ion-channel conformations to a transmembrane ion gradient. Science (1990) 2.80
Silver as a probe of pore-forming residues in a potassium channel. Science (1995) 2.78
Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor. Science (1989) 2.75
Functional reconstitution of a prokaryotic K+ channel. J Gen Physiol (1998) 2.66
A voltage-gated anion channel from the electric organ of Torpedo californica. J Biol Chem (1979) 2.65
Voltage-gated cation conductance channel from fragmented sarcoplasmic reticulum: steady-state electrical properties. J Membr Biol (1978) 2.57
The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition. Neuron (1994) 2.55
Effects of phospholipid surface charge on ion conduction in the K+ channel of sarcoplasmic reticulum. Biophys J (1984) 2.46
Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother (1975) 2.38
Laboratory and bedside evaluation of portable glucose meters. Am J Clin Pathol (1995) 2.35
Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol (1992) 2.32
A voltage-dependent chloride conductance channel from Torpedo electroplax membrane. Ann N Y Acad Sci (1980) 2.26
Batrachotoxin-activated Na+ channels in planar lipid bilayers. Competition of tetrodotoxin block by Na+. J Gen Physiol (1984) 2.26
Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol (1995) 2.25
Role of surface electrostatics in the operation of a high-conductance Ca2+-activated K+ channel. Biochemistry (1989) 2.25
Human immunodeficiency virus infection in disadvantaged adolescents. Findings from the US Job Corps. JAMA (1991) 2.24
Purification, reconstitution, and subunit composition of a voltage-gated chloride channel from Torpedo electroplax. Biochemistry (1994) 2.21
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology (2010) 2.17
Food service and foods and beverages available at school: results from the School Health Policies and Programs Study 2000. J Sch Health (2001) 2.16
Allosteric effects of Mg2+ on the gating of Ca2+-activated K+ channels from mammalian skeletal muscle. J Exp Biol (1986) 2.14
High-level expression, functional reconstitution, and quaternary structure of a prokaryotic ClC-type chloride channel. J Gen Physiol (1999) 2.12
Treatment of bacterial endocarditis with cephalothin. N Engl J Med (1968) 2.12
Helical structure and packing orientation of the S2 segment in the Shaker K+ channel. J Gen Physiol (1999) 2.10
Thermodynamic and kinetic studies of the gating behavior of a K+-selective channel from the sarcoplasmic reticulum membrane. J Gen Physiol (1980) 2.06
Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia (2007) 2.06
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05
Ca++-induced fusion of fragmented sarcoplasmic reticulum with artificial planar bilayers. J Membr Biol (1976) 2.04
A K+-selective, three-state channel from fragmented sarcoplasmic reticulum of frog leg muscle. J Membr Biol (1981) 2.04
Conduction and block by organic cations in a K+-selective channel from sarcoplasmic reticulum incorporated into planar phospholipid bilayers. J Gen Physiol (1982) 2.00
Mechanism of charybdotoxin block of a voltage-gated K+ channel. Biophys J (1993) 1.99
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Trapping single ions inside single ion channels. Biophys J (1987) 1.94
Tetrameric stoichiometry of a prokaryotic K+ channel. Biochemistry (1997) 1.94
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
More on epidural needle wings. Anaesthesia (2006) 1.92
Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol (2000) 1.90
A decade of CLC chloride channels: structure, mechanism, and many unsettled questions. Annu Rev Biophys Biomol Struct (2000) 1.89
Tethered blockers as molecular 'tape measures' for a voltage-gated K+ channel. Nat Struct Biol (2000) 1.89
Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89
Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel. Neuron (1992) 1.87
The lipid-protein interface of a Shaker K(+) channel. J Gen Physiol (2000) 1.85
Voltage-dependent blockade of muscle Na+ channels by guanidinium toxins. J Gen Physiol (1984) 1.84
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J (2010) 1.84
Communicating health information through the entertainment media. Health Aff (Millwood) (2001) 1.83
LR white resin and improved on-grid immunogold detection of vicilin, a pea seed storage protein. Cell Biol Int Rep (1984) 1.82
Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab (1999) 1.81
Bloodstream infections in the elderly. Am J Med (1989) 1.80
Purification of charybdotoxin, a specific inhibitor of the high-conductance Ca2+-activated K+ channel. J Biol Chem (1986) 1.80
Physician-patient discussions of controversial cancer screening tests. Am J Prev Med (2001) 1.80
Isolated-patch recording from liposomes containing functionally reconstituted chloride channels from Torpedo electroplax. Proc Natl Acad Sci U S A (1982) 1.77
Role of rpoS (katF) in oxyR-independent regulation of hydroperoxidase I in Escherichia coli. Mol Microbiol (1994) 1.77
Distribution and activation of the Golgi apparatus in geotropism. Plant Physiol (1972) 1.75
Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Arch Intern Med (1996) 1.73
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
A comparison of eubacterial and archaeal structure-specific 5'-exonucleases. J Biol Chem (1999) 1.72
Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol (1992) 1.71
Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin. Biochemistry (1994) 1.69
Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care (2003) 1.69
Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis (2011) 1.69
Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res (2000) 1.68
Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother (1976) 1.68
Patient survival factors in paranasal sinus mucormycosis. Laryngoscope (1980) 1.68
Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res (1987) 1.67
Be wary of subsidising nicotine replacement therapy. Tob Control (2002) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67